{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:38:29Z","timestamp":1788273509095,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ygyno.2007.11.005","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T12:20:02Z","timestamp":1200313202000},"page":"546-548","source":"Crossref","is-referenced-by-count":12,"title":["Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer"],"prefix":"10.1016","volume":"111","author":[{"given":"Barbara M.","family":"Buttin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.11.005_bib1","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ygyno.2007.11.005_bib2","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2002.02.116","article-title":"Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma","volume":"20","author":"Rajkumar","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.11.005_bib3","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1200\/JCO.2005.04.054","article-title":"Thalidomide-induced interstitial pneumonitis","volume":"23","author":"Onozawa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.11.005_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0272-5231(03)00143-6","article-title":"Bronchoalveolar lavage in drug-induced lung disease","volume":"25","author":"Costabel","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ygyno.2007.11.005_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ygyno.2006.05.035","article-title":"Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma","volume":"103","author":"Chan","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.11.005_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/jpm.2006.0083","article-title":"Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer","volume":"10","author":"Gordinier","year":"2007","journal-title":"J Palliative Med"},{"key":"10.1016\/j.ygyno.2007.11.005_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1345\/aph.1E608","article-title":"Dyspnea during thalidomide treatment for advanced ovarian cancer","volume":"39","author":"Gordinier","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ygyno.2007.11.005_bib8","first-page":"492","article-title":"Lung toxicity due to thalidomide [Spanish]","volume":"38","author":"Carrion Valero","year":"2002","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.ygyno.2007.11.005_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00045391-200305000-00011","article-title":"Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomide","volume":"10","author":"Behrens","year":"2003","journal-title":"Am J Ther."},{"key":"10.1016\/j.ygyno.2007.11.005_bib10","unstructured":"Downs Jr L, Judson P, Argenta P, Ghebre R, Geller MA, Bliss RL, et al. A prospective randomized trial of thalidomide with topotecan compared to topotecan alone in women with recurrent epithelial ovarian, primary peritoneal or fallopian tube carcinoma. Cancer in press [Electronic publication ahead of print]."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807009043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T14:53:50Z","timestamp":1546354430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807009043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0090825807009043"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.11.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}